Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
8 pending office actions • 1 client • 7 examiners • 3 art units • 0 of 8 (0%) have an AI response strategy ready
Law Office of Michael A. Sanzo, LLC manages a portfolio in Biotechnology & Pharmaceuticals with 695 career applications. The firm maintains a resolved allowance rate of 77.13 percent for applications that reach a final resolution. Achieving these results involves an average of 3.4 office actions per allowance. Currently, the firm has 6 pending office actions to address.
The 695 career applications and 77.13 percent allowance rate reflect the firm's practice in its primary technology area. The 3.4 average office actions per allowance provides a benchmark for expected examiner interaction during the patent acquisition process. These figures offer a data-grounded view of the firm's historical performance and current workload for practitioners evaluating the firm's Biotechnology & Pharmaceuticals experience.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (12%) |
| §101 + other | 1 (12%) |
| §103 only | 1 (12%) |
| §102 only | 1 (12%) |
| §112 only | 1 (12%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 2 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RIOJA, MELISSA A | 2 | 49.5% | +53.8% |
| HOPKINS, ROBERT A | 1 | 84.5% | +7.5% |
| SAWYER, JENNIFER C | 1 | 68.6% | -8.4% |
| OGUNBIYI, OLUWATOSIN A | 1 | 63.7% | +41.4% |
| NGUYEN, HA S | 1 | 58.7% | -21.0% |
| HINES, JANA A | 1 | 53.0% | +39.7% |
| XU, QING | 1 | 50.9% | +55.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18293016 | MICROORGANISMS DISPLAYING VIRAL DECOY RECEPTORS | OGUNBIYI, OLUWATOSIN A | 22d |
| 17627399 | METHOD FOR DETERMINING THE RISK OF AN AVIAN PATHOGENIC E. COLI (APEC) INFECTION IN AN AVIAN FLOCK | HINES, JANA A | 30d |
| 18750658 | METHOD FOR GAS SEPARATION BY MEMBRANES | HOPKINS, ROBERT A | — |
| 18641381 | FOAM STABILIZERS FOR PHENOLIC FOAM | RIOJA, MELISSA A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18293016 | MICROORGANISMS DISPLAYING VIRAL DECOY RECEPTORS | OGUNBIYI, OLUWATOSIN A | 22d |
| 17627399 | METHOD FOR DETERMINING THE RISK OF AN AVIAN PATHOGENIC E. COLI (APEC) INFECTION IN AN AVIAN FLOCK | HINES, JANA A | 30d |
| 18641381 | FOAM STABILIZERS FOR PHENOLIC FOAM | RIOJA, MELISSA A | — |
| 18265430 | PRODUCTION OF POLYURETHANE FOAM | RIOJA, MELISSA A | — |
| 17421917 | FERMENTATION BROTHS AND THEIR USE | XU, QING | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Evonik | 8 |
| Art Unit | Apps |
|---|---|
| 1645 | 2 |
| 1764 | 1 |
| 1656 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18750658 | METHOD FOR GAS SEPARATION BY MEMBRANES | Evonik Operations GmbH | HOPKINS, ROBERT A | §102§103§112 | Non-Final OA | — | Pending | Jun 21, 2024 | |
| 18641381 | FOAM STABILIZERS FOR PHENOLIC FOAM | Evonik Operations GmbH | RIOJA, MELISSA A | §103§112 | Non-Final OA | — | Pending | Apr 21, 2024 | |
| 18588296 | RECOVERY OF SILOXANE CYCLES | Evonik Operations GmbH | SAWYER, JENNIFER C | §103§112DP | Non-Final OA | — | Pending | Feb 27, 2024 | |
| 18293016 | MICROORGANISMS DISPLAYING VIRAL DECOY RECEPTORS | Evonik Operations GmbH | OGUNBIYI, OLUWATOSIN A | 1645 | §101 | Non-Final OA | 22d | Pending | Jan 29, 2024 |
| 18542990 | MELT-PROCESSABLE POLYIMIDES WITH HIGH GLASS TRANSITION TEMPERATURE | Evonik Fibres GmbH | NGUYEN, HA S | §102 | Non-Final OA | — | Pending | Dec 18, 2023 | |
| 18265430 | PRODUCTION OF POLYURETHANE FOAM | Evonik Operations GmbH | RIOJA, MELISSA A | 1764 | §112 | Non-Final OA | — | Pending | Jun 05, 2023 |
| 17627399 | METHOD FOR DETERMINING THE RISK OF AN AVIAN PATHOGENIC E. COLI (APEC) INFECTION IN AN AVIAN FLOCK | Evonik Operations GmbH | HINES, JANA A | 1645 | §101§102§112 | Non-Final OA | 30d | Pending | Jan 14, 2022 |
| 17421917 | FERMENTATION BROTHS AND THEIR USE | Evonik Operations GmbH | XU, QING | 1656 | §103 | Final Rejection | — | Pending | Jul 09, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial